Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidetoshi Hayashi

Showing results (51-60 of 333) with videos related to

Pageof 34
Sort By:
Oncology Reports|November 29, 2018
Dual blockade of EGFR tyrosine kinase using osimertinib and afatinib eradicates EGFR‑mutant Ba/F3 cellsKimio Yonesaka, Yoshihisa Kobayashi, Hidetoshi Hayashi, et al.
ESMO Open|August 2, 2017
Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumabRyoji Kato, Hidetoshi Hayashi, Junko Tanizaki, et al.
ESMO Open|August 30, 2017
Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFRHitomi Sakai, Hidetoshi Hayashi, Tsutomu Iwasa, et al.
Biological & Pharmaceutical Bulletin|July 8, 2010
Dual mode of regulation of cell division cycle 25 A protein by TRB3Satoshi Sakai, Nobumichi Ohoka, Kikuo Onozaki, et al.
Oncotarget|July 24, 2018
Treatment of <i>EGFR</i> mutation-positive non-small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case reportYoshikane Nonagase, Masayuki Takeda, Kaoru Tanaka, et al.
Biochemical and Biophysical Research Communications|February 1, 2003
TGFbeta down-regulates IFN-gamma production in IL-18 treated NK cell line LNK5E6Hidetoshi Hayashi, Yasumichi Inoue, Hiroko Tsutsui, et al.
Current Cancer Drug Targets|November 13, 2015
Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer DevelopmentSatoshi Sakai, Chiharu Miyajima, Chiharu Uchida, et al.
Clinical Lung Cancer|June 4, 2017
Prognostic Impact of Minimal Pericardial Effusion in Patients With Advanced Non-small-cell Lung CancerRyoji Kato, Hidetoshi Hayashi, Yasutaka Chiba, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
17beta-estradiol induces IL-1alpha gene expression in rheumatoid fibroblast-like synovial cells through estrogen receptor alpha (ERalpha) and augmentation of transcriptional activity of Sp1 by dissociating histone deacetylase 2 from ERalphaYuka Itoh, Hidetoshi Hayashi, Keiji Miyazawa, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2013
Postprogression survival for first-line chemotherapy in patients with advanced gastric cancerHisato Kawakami, Isamu Okamoto, Hidetoshi Hayashi, et al.
Pageof 34

Showing results (51-60 of 333) with videos related to

Sort By:
Pageof 34
Oncology Reports|November 29, 2018
Dual blockade of EGFR tyrosine kinase using osimertinib and afatinib eradicates EGFR‑mutant Ba/F3 cellsKimio Yonesaka, Yoshihisa Kobayashi, Hidetoshi Hayashi, et al.
ESMO Open|August 2, 2017
Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumabRyoji Kato, Hidetoshi Hayashi, Junko Tanizaki, et al.
ESMO Open|August 30, 2017
Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFRHitomi Sakai, Hidetoshi Hayashi, Tsutomu Iwasa, et al.
Biological & Pharmaceutical Bulletin|July 8, 2010
Dual mode of regulation of cell division cycle 25 A protein by TRB3Satoshi Sakai, Nobumichi Ohoka, Kikuo Onozaki, et al.
Oncotarget|July 24, 2018
Treatment of <i>EGFR</i> mutation-positive non-small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case reportYoshikane Nonagase, Masayuki Takeda, Kaoru Tanaka, et al.
Biochemical and Biophysical Research Communications|February 1, 2003
TGFbeta down-regulates IFN-gamma production in IL-18 treated NK cell line LNK5E6Hidetoshi Hayashi, Yasumichi Inoue, Hiroko Tsutsui, et al.
Current Cancer Drug Targets|November 13, 2015
Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer DevelopmentSatoshi Sakai, Chiharu Miyajima, Chiharu Uchida, et al.
Clinical Lung Cancer|June 4, 2017
Prognostic Impact of Minimal Pericardial Effusion in Patients With Advanced Non-small-cell Lung CancerRyoji Kato, Hidetoshi Hayashi, Yasutaka Chiba, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
17beta-estradiol induces IL-1alpha gene expression in rheumatoid fibroblast-like synovial cells through estrogen receptor alpha (ERalpha) and augmentation of transcriptional activity of Sp1 by dissociating histone deacetylase 2 from ERalphaYuka Itoh, Hidetoshi Hayashi, Keiji Miyazawa, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2013
Postprogression survival for first-line chemotherapy in patients with advanced gastric cancerHisato Kawakami, Isamu Okamoto, Hidetoshi Hayashi, et al.
Pageof 34